Artificial intelligence (AI) has moved from pilot to practice inside medical affairs functions across the pharmaceutical and life sciences industry. On April 30, 2026, a group of senior medical affairs, agency, and accreditation leaders convened following a summit meeting for a two-hour discussion on the present state and near-future trajectory of AI in medical affairs. This consensus statement su...